Regencell Bioscience Holdings (RGC) Non-Current Assets (2020 - 2025)

Regencell Bioscience Holdings has reported Non-Current Assets for 6 years, with the latest figure at $656170.0 in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets changed N/A year-over-year to $656170.0; the trailing twelve-month figure through Dec 2025 stood at $656170.0 (changed N/A YoY), and the FY2025 full-year result was $852769.0, up 163.04% from the prior year.
• Non-Current Assets for Q4 2025 stood at $656170.0, down from $852769.0 in the prior quarter.
• The five-year high for Non-Current Assets was $1.6 million in Q2 2022, with the low at $273285.0 in Q2 2021.
• Historically, Non-Current Assets has averaged $780192.7 across 5 years, with a median of $754469.5 in 2025.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 476.07% — and 2024, when it slumped 67.59%.
• Regencell Bioscience Holdings' Non-Current Assets stood at $273285.0 in 2021, then soared by 476.07% to $1.6 million in 2022, then slumped by 36.45% to $1.0 million in 2023, then tumbled by 67.59% to $324198.0 in 2024, then soared by 102.4% to $656170.0 in 2025.
• The last three Non-Current Assets figures came in at $656170.0 (Q4 2025), $852769.0 (Q2 2025), and $324198.0 (Q2 2024), per Business Quant data.